Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Reliq Health Technologies Inc V.RHT

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a Canada-based global healthcare technology company that specializes in developing virtual care solutions. The Company's target markets include virtual care, long-term care and big data. iUGO Care, the Company's platform, is a software as a service solution that supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, remote therapeutic monitoring and wound care. Its behavioral health integration service supports patients with any mental, behavioral, or psychiatric health diagnoses by integrating mental health, psychiatric care, counseling, and addiction services with primary care.


TSXV:RHT - Post by User

Post by jimitwiston May 19, 2022 1:58pm
192 Views
Post# 34695920

35,000 new patients to onboard since January 1

35,000 new patients to onboard since January 1Since January 1st RHT  has announced contracts to onboard 35,000 new patients, that does not include the 10,000 musculoskeletal patients contract that was announced. If all these new patients are onboarded, that would be 85,000 total patients, at $40 per patient, that would be a monthly run rate of $3.4 million. Considering that that forecast was $4 million by year end, the future share price should rise nicely. 
<< Previous
Bullboard Posts
Next >>